ATLANTA, GA — (Marketwire) — 05/11/12 — Crown Dynamics Corp., (OTCBB: CDYY) today shares additional information from the clinical trials conducted on their Airware Labs AIR® Breathe product.
The published clinical trial was designed to determine if a product that acted as an internal nasal dilator (as opposed to adhesive nasal strips placed on the outside of the nose) would effectively decrease snoring. The clinical trials conducted for the AIR® Breathe product tested both efficacy for the user and improved quality of sleep for their partners.
The effectiveness of the AIR® Breathe product proved to be overwhelmingly positive, demonstrating substantial alleviation of snoring in AIR® Breathe users, resulting in sounder, more restful sleep for them as well as % of their bed partners.
David Dolezal, President of Airware Labs commented, “The test results were well beyond our original expectations. In addition to alleviating snoring, we discovered that AIR® Breathe increases airflow up to 38% more than adhesive nasal strips. Armed with this knowledge, our Airware Lab–s Team has created AIR® product extensions for travel, headache, congestion, allergies, and more.” He adds, “We will continue to create innovative, drug-free solutions designed help people improve their life through better breathing.”
Snoring is a widespread and chronic problem. Epidemiologic data indicates that up to 50% of adults snore on a regular basis. Not only is snoring bothersome to bed partners — who on average lose 2 hours of sleep per night, it has other serious health ramifications. Snoring is an auditory reminder that obstruction of the airway is occurring, and has been linked to increases in blood pressure, heart attack, and stroke.
Following are key findings obtained from the clinical trials:
AIR® Breathe was shown to be clinically significant in reducing the number of snoring events
88% of bed partners said their sleep quality improved
Bed partner subjective sleep quality and quantity was overwhelmingly reported as improved, when snorer was using AIR®Breathe.
Overall, results of the study suggest a clinically significant therapeutic effect of the unique internal nasal dilator device for the reduction in snoring events, and also suggest significant improvement of bed partner sleep quality and sleep quantity.
The clinical research findings were published in the September-October issue of , conducted by Dr. Barbara Harris, Dr. Michael Breus, Dr. Thomas Minor and Yiran Hu, MS. Ongoing studies are being conducted on all of the AIR® products.
For more information please see
Crown Dynamics provides innovative technology solutions and consumer product offerings that promote better health and enhance the wellbeing of people. Crown Dynamics–, products and services, such as AIR® by AirWare Labs, provide consumers around the world with safe and effective methods to control their own personal environment. AIR® filter products contain 3M filters for allergy sufferers and for mass-transit travelers. Other AIR® products help with congestion, insomnia, headaches, nausea and snoring. Crown–s Pomcom and Watchtower technology provide point-of-care protection at home or in an assisted living environment. This technology is designed to enhance the personal safety of seniors and people with special needs, allowing them to live fuller, more independent lives.
This press release contains forward-looking statements that involve risks and uncertainties, including the Company–s beliefs about its business prospects and future results of operations. These results may not indicative of the result achieved in the entire tailings pile do to the non-homogenous nature of the pile itself. Some factors that could cause actual results to differ materially include economic and operational risks, changes in anticipated earnings, continuation of current contracts, and other factors detailed in the Company–s filings with the Securities and Exchange Commission, including its most recent Forms 10-KSB and 10-QSB. The Company forecasts provided above are dynamic and therefore refer only to this release date. The Company does not undertake to update any forecasts that it may make available to the investing public. Please visit
Crown Dynamics Corporation
5400 Laurel Springs Pkwy, Suite 107
Suwanee, GA 30024
Office: 1.480.767.9700
Fax: 480.212.9171
Email: